Acessibilidade / Reportar erro

Patients with autosomal dominant spinocerebellar ataxia have more risk of falls, important balance impairment, and decreased ability to function

Pacientes com ataxia espinocerebelar autossômica dominante apresentam maior risco de quedas, déficit de equilíbrio corporal e redução da capacidade funcional

Abstracts

OBJECTIVES:

To assess balance and ability to function in patients with spinocerebellar ataxia.

METHODS:

A total of 44 patients with different spinocerebellar ataxia types 1, 2, 3, and 6 were evaluated using the Tinetti balance and gait assessment and the functional independence measure. The scale for the assessment and rating of ataxia and the international cooperative ataxia rating scale were used to evaluate disease severity.

RESULTS:

Most patients showed significant risk of falls. The balance scores were significantly different in spinocerebellar ataxia types. A significant positive correlation between balance and disease severity was found.

CONCLUSION:

Patients with spinocerebellar ataxia have important balance impairment and risk of falls that influence the ability to function such as self-care, transfers, and locomotion. Furthermore, the more severe ataxia is, the more compromised are postural balance, risk of falls, and ability to function.

spinocerebellar ataxias; postural balance; risk of falls; ability to function


OBJETIVOS:

Avaliar o equilíbrio e a capacidade funcional em pacientes com ataxia espinocerebelar.

MÉTODOS:

Quarenta e quatro pacientes com diferentes tipos de ataxia espinocerebelar foram avaliados usando os testes de equilíbrio e de marcha de Tinetti, e da Medida de Independência Funcional. A Escala para Avaliação e Graduação de Ataxia e a Escala Cooperativa Internacional para Graduação de Ataxia foram utilizadas para avaliar a gravidade da doença.

RESULTADOS:

A maioria dos pacientes apresentou risco significativo de quedas. As pontuações de equilíbrio foram diferentes entre os tipos de ataxia espinocerebelar. Foi encontrada correlação positiva entre o déficit de equilíbrio e a gravidade da doença.

CONCLUSÃO:

Os pacientes com ataxia espinocerebelar possuem comprometimento importante do equilíbrio e risco de quedas, que influenciam a capacidade funcional, como por exemplo: auto-cuidado, transferências e locomoção. Além disso, quanto mais grave a ataxia, maior o comprometimento do equilíbrio postural, do risco de quedas, e da capacidade funcional.

ataxias espinocerebelares; equilíbrio; risco de quedas; capacidade funcional


Spinocerebellar ataxias (SCA) comprise a group of autosomal dominant neurodegenerative disorders with involvement of the cerebellum and its afferent and efferent pathways11. Walshe JM. Wilson's Disease. New oral therapy. Lancet 1956;1:25-26.,22. Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.. Disease onset usually occurs in individuals between the third and fifth decade of life with great variability of clinical presentations33. Bull PC, Thomas GR, Forbes J, Rommens JM, Cox DW. The Wilson disease gene is a putative copper transporting p-type ATPase similar to Menkes gene. Nat Genet 1993;5:327-337.. The most common SCA are characterized by expanded CAG trinucleotide that repeats the encode glutamine amino acid, the so-called polyglutamine diseases. So far, more than 30 SCA types have been described.

Balance disturbance in ataxias results in increased postural sway, excessive or reduced response to disturbances, poor balance control during body movements, and unusual body oscillation. It may be a consequence of motor unit recruitment order reversals, delayed recruitment of proximal synergic muscles or coactivation of antagonist muscles, delayed activation of postural responses, inadequate amplitudes of muscle responses, and motor adaptation to tasks and environment. The cerebellum cannot sort out inputs from other systems and balance muscle activities for effective timely contractions and appropriate control of upright standing. Thus, impaired balance and lack of coordination in the lower limbs result in oscillations in the orthostatic position and ataxic gait44. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-277.,55. Petrukhin KE, Lutsenko S, Chernov I, et al. Characterization of the Wilson disease gene encoding a P-type copper transposting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994;3:1647-1656..

Gait instability and coordination impairment are the main features in patients with SCA. They may lead to significant functional decline in activities of daily living (ADLs) and social activities and increased dependence. However, the impact of these features in each type of SCA is not yet known since they have different phenotypes and clinical presentations.

This study aimed to evaluate static and dynamic balance and ability to function in patients with different types of SCA and to correlate them with ataxia severity and disease duration.

METHODS

A cross-sectional observational study was performed in a sample of patients with SCA followed up in the Ataxia Unit at Universidade Federal de São Paulo (UNIFESP) in São Paulo, Brazil. All patients signed a free consent form approved by our institutional research board. Patients with clinical and molecular-proven SCA types 1, 2, 3, and 6 were included in the study. Wheelchair patients and those with major cognitive deficit (mini-mental state examination [MMSE] score <24 or <19 if illiterate)66. Behari M, Pardasani V. Genetics of Wilson's disease. Parkinson Relat Disord 2010;16:639-644.

7. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
-88. Kenney SM, Cox DW. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007;28:1171-1177. were excluded. SCA7 patients were excluded due to visual impairment.

Forty-six patients with SCA were evaluated: 4 were SCA1; 12 SCA2; 21 SCA3, and 9 SCA6. Their age ranged from 21 to 84 years. One patient with SCA2 and one SCA6 were excluded due to cognitive impairment (MMSE score <24). Thus, a total of 44 patients were evaluated using clinical scales. Of them, 23 were males and 21 females with disease duration ranging from 3 to 28 years.

Balance was assessed using the Tinetti balance and gait assessment. The Tinetti test (TT) consists of two scales with a total score of 28. A score lower than 19 indicates high risk of falls99. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006;120:151-159.

10. Deguti MM, Genschel J, Cançado ELR, et al. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 2004;398:1-8.

11. Caca K, Ferenci P, Kühn HJ, et al. High prevalence of the H1069Q mutation in East german patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001;35:575-581.
-1212. Loudianos G, Dessi V, Lovicu M, et al. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 1998;12:89-94.. Ability to function was evaluated using the functional independence measure (FIM). The FIM is an 18-item scale that assesses performance in common daily life tasks in six subscales: self-care, sphincter control, transfers, locomotion, communication, and social cognition. This scale's scores range from 18 to 126, and high scores indicate good functional independence in ADLs1313. Corrêa LS. As políticas públicas de imigração européia não portuguesa para o Brasil - de Pombal à República. Rev Geo Paisagem 2005;4:8.

14. Instituto Brasileiro de Geografia e Estatística (IBGE). Brasil 500 anos de povoamento. Rio de Janeiro: IBGE, 2000.
-1515. Gupta A, Aikath D, Neogi R, et al. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 2005;118:49-57..

To assess disease severity, the scale for the assessment and rating ataxia (SARA)1616. Mak CM, Lam CW, Tam S, et al. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008;53:55-63. and the international cooperative ataxia rating scale (ICARS) were used. The same researcher (C.Y.P.A.) performed all clinical assessments using the scales mentioned before.

STATISTICAL ANALYSIS

Normal distribution of data was confirmed using the Kolmogorov-Smirnov test. Comparisons between groups were carried out using Student's t-test. Correlations among disease time, SARA, ICARS, and TT were assessed using Pearson's test. ANOVA was used to compare SCA types regarding Tinetti fall risk index and ANOVA with repeated measures was used to compare them regarding the FIM results. A corrected p-value of 0.05 was set for statistical significance.

RESULTS

Static and dynamic balance, fall risk, and ability to function were impaired in SCA patients. No significant difference was found regarding dynamic balance and Tinetti fall risk index when we compared one SCA type with another. However, significantly different scores were found in the static balance scale (p=0.024) comparing different SCA types (Table 1). Note that only SCA6 patients showed no risk of falls (Tinetti fall risk index >19).

Table 1
Comparison between spinocerebellar ataxia types and Tinetti fall risk index scores.

Ability to function was assessed through the FIM scale and was significantly impaired in SCA patients (Table 2). No significant difference was found in the ability to function when we compared different SCA types.

Table 2
Comparison between functional independence measure subscales for each spinocerebellar ataxia type.

A positive correlation was found between balance impairment (static and dynamic balance - Tinetti fall risk Index) and functional disability (FIM scale) (r=0.63) (Figure). It was also found that the subscales related to self-care, transfers, and locomotion were the most affected among all SCA patients.

Figure
Correlation between total Tinetti and functional independence measure scores in all spinocerebellar ataxia patients.

A negative correlation was found between balance impairment and disease severity measured through the SARA and ICARS scales (r=-0.73 SARA; r=-0.71 ICARS). A negative correlation was also found between ability to function and disease severity (r=-0.625 SARA; r=-0.54 ICARS) as well as in the FIM subscales related to self-care, transfers, and locomotion.

DISCUSSION

Our study demonstrated that SCA patients have important static and dynamic balance impairment and higher risk of falls. These features have a direct impact on their ability to function including self-care, transfers, and locomotion. Additionally, there was a clear positive correlation between balance impairment and functional disability and disease severity. Conversely, no correlation was found between balance impairment and disability and disease duration, except for SCA2 patients. This study also showed that functional disability and dynamic balance are not affected by the SCA type, but patients with different SCA types showed varying degrees of static balance impairment.

According to previous data and based on our personal clinical experience, the most common symptom in SCA patients are balance problems and gait disturbances leading to impaired daily functions and locomotion99. Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006;120:151-159.,1717. Shah AB, Chernov I, Zhang HT, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997;61:317-328.,1818. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-217.. In 2009, Leonardi et al1717. Shah AB, Chernov I, Zhang HT, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997;61:317-328.. showed a positive correlation between balance impairment and risk of falls in seven patients with SCA evidencing through clinical scales that ataxic gait and lack of coordination may lead to static and dynamic imbalance and higher propensity to falls. This is in line with our findings; we demonstrated through clinical scales that patients with SCA have significant balance impairment and higher risk of falls. Interestingly, higher risk of falls was not evidenced in SCA6 patients, probably because they present a pure presentation with late onset of symptoms.

It must be borne in mind that each SCA type has different neurological signs and symptoms associated with ataxia - for instance, neuropathy and ophthalmoparesis in SCA2 and SCA3, pyramidal signs in SCA1, and dystonia, and other extrapyramidal signs in SCA31919. Panagiotakaki E, Tzetis M, Manolaki N, et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet 2004;131:168-173.

20. Schiefermeier M, Kollegger H, Madl C, et al. The impact of apolipoprotein E genotypes on age of onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000;123:585-590.

21. Merle U, Stremmel W, Gessner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol 2006;17:549-552.
-2222. Gupta A, Chattopadhyay I, Mukherjee S, et al. A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson disease patient. Behav Brain Funct 2010;6:33.. Therefore, we hypothesized that there will be differences in balance impairment and ability to function in different SCA types. Consistent with that, significantly different degrees of balance impairment were found among SCA types. We can assume that other signs and symptoms other than ataxia may have a great impact on balance, and that patients with SCA1 showed the worst performance.

Regarding the assessment of ability to function (FIM scale) in these patients, most showed functional scores (FIM >104) and modified independence. In other words, they had difficulty to perform some daily tasks. A comparison of the subscales in SCA patients showed different performance and ability to function in specific subscales. The patients showed greater difficulty and dependence in the subscales of self-care, transfers, and locomotion correlated to FIM motor scores1313. Corrêa LS. As políticas públicas de imigração européia não portuguesa para o Brasil - de Pombal à República. Rev Geo Paisagem 2005;4:8., which are directly related to balance. A comparison of ability to function between different SCA types found no differences in all FIM scales, suggesting that all patients regardless of the SCA type have similar difficulty in performing ADLs.

Moreover, a positive correlation between balance impairment and ability to function was found in the entire sample and in all SCA types, except for SCA1 patients. This analysis also showed that the subscales related to self-care, transfers, and locomotion are the most affected in these patients and are the most strongly correlated with balance impairment. Therefore, balance impairment had a direct impact on performance of these three tasks, which is consistent with the main complaints reported by these patients in clinical practice.

Our study failed to demonstrate a correlation between disease duration and balance impairment and functional disability. On the other hand, we found a clear correlation between ataxia severity and balance impairment and functional disability and offered strong evidence that these two skills are affected by age in SCA patients.

There are some limitations in our study. First, noncerebellar signs including spasticity, neuropathy, and extrapyramidal signs were not assessed and an accurate measure of their impact on balance and gait of patients was not possible. Furthermore, our group of SCA patients was heterogeneous, since only four patients with SCA1 were evaluated compared with 21 patients with SCA3. This may explain some different findings in patients with SCA1 compared with the total sample.

In conclusion, this study demonstrated that SCA patients have significant static and dynamic balance impairment and higher risk of falls that have a direct impact on their ability to function, especially regarding self-care, transfers, and locomotion. Also, balance and ability to function were influenced by ataxia severity, and functional disability increases with age in SCA patients. As for each SCA type, there were different degrees of balance impairment. Further studies in SCA patients are necessary to better understand the clinical features that may have an impact on balance and ability to function. This knowledge may be valuable for future planning rehabilitation and physical therapy interventions.

References

  • 1
    Walshe JM. Wilson's Disease. New oral therapy. Lancet 1956;1:25-26.
  • 2
    Tanzi RE, Petrukhin K, Chernov I, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:344-350.
  • 3
    Bull PC, Thomas GR, Forbes J, Rommens JM, Cox DW. The Wilson disease gene is a putative copper transporting p-type ATPase similar to Menkes gene. Nat Genet 1993;5:327-337.
  • 4
    Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993;197:271-277.
  • 5
    Petrukhin KE, Lutsenko S, Chernov I, et al. Characterization of the Wilson disease gene encoding a P-type copper transposting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994;3:1647-1656.
  • 6
    Behari M, Pardasani V. Genetics of Wilson's disease. Parkinson Relat Disord 2010;16:639-644.
  • 7
    Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
  • 8
    Kenney SM, Cox DW. Sequence variation database for the Wilson disease copper transporter, ATP7B. Hum Mutat 2007;28:1171-1177.
  • 9
    Ferenci P. Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. Hum Genet 2006;120:151-159.
  • 10
    Deguti MM, Genschel J, Cançado ELR, et al. Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients. Hum Mutat 2004;398:1-8.
  • 11
    Caca K, Ferenci P, Kühn HJ, et al. High prevalence of the H1069Q mutation in East german patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis. J Hepatol 2001;35:575-581.
  • 12
    Loudianos G, Dessi V, Lovicu M, et al. Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 1998;12:89-94.
  • 13
    Corrêa LS. As políticas públicas de imigração européia não portuguesa para o Brasil - de Pombal à República. Rev Geo Paisagem 2005;4:8.
  • 14
    Instituto Brasileiro de Geografia e Estatística (IBGE). Brasil 500 anos de povoamento. Rio de Janeiro: IBGE, 2000.
  • 15
    Gupta A, Aikath D, Neogi R, et al. Molecular pathogenesis of Wilson disease: haplotype analysis, detection of prevalent mutations and genotype-phenotype correlation in Indian patients. Hum Genet 2005;118:49-57.
  • 16
    Mak CM, Lam CW, Tam S, et al. Mutational analysis of 65 Wilson disease patients in Hong Kong Chinese: identification of 17 novel mutations and its genetic heterogeneity. J Hum Genet 2008;53:55-63.
  • 17
    Shah AB, Chernov I, Zhang HT, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997;61:317-328.
  • 18
    Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW. The Wilson disease gene: spectrum of mutations and their consequences. Nat Genet 1995;9:210-217.
  • 19
    Panagiotakaki E, Tzetis M, Manolaki N, et al. Genotype-phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). Am J Med Genet 2004;131:168-173.
  • 20
    Schiefermeier M, Kollegger H, Madl C, et al. The impact of apolipoprotein E genotypes on age of onset of symptoms and phenotypic expression in Wilson's disease. Brain 2000;123:585-590.
  • 21
    Merle U, Stremmel W, Gessner R. Influence of homozygosity for methionine at codon 129 of the human prion gene on the onset of neurological and hepatic symptoms in Wilson disease. Arch Neurol 2006;17:549-552.
  • 22
    Gupta A, Chattopadhyay I, Mukherjee S, et al. A novel COMMD1 mutation Thr174Met associated with elevated urinary copper and signs of enhanced apoptotic cell death in a Wilson disease patient. Behav Brain Funct 2010;6:33.

Publication Dates

  • Publication in this collection
    Aug 2013

History

  • Received
    21 Jan 2012
  • Reviewed
    02 Apr 2013
  • Accepted
    09 Apr 2013
Academia Brasileira de Neurologia - ABNEURO R. Vergueiro, 1353 sl.1404 - Ed. Top Towers Offices Torre Norte, 04101-000 São Paulo SP Brazil, Tel.: +55 11 5084-9463 | +55 11 5083-3876 - São Paulo - SP - Brazil
E-mail: revista.arquivos@abneuro.org